Drug treatments for covid-19: living systematic review and network meta-analysis

Cites (222)

Items 201–222 of 222

1. Prophylaxis for covid-19: living systematic review and network meta-analysis
   Jessica Julia Bartoszko, Reed Alexander Cunningham Siemieniuk, Elena Kum et al. · 2021 · medRxiv
2. A two-arm, randomized, controlled, multi-centric, open-label Phase-2 study to evaluate the efficacy and safety of Itolizumab in moderate to severe ARDS patients due to COVID-19
   Suresh Kumar, Rosemarie de Souza, Milind Nadkar · 2020 · medRxiv
3. A Randomized Controlled Study Of Favipiravir Vs Hydroxychloroquine In COVID-19 Management: What Have We Learned So Far?
   H. Dabbous, M. El-Sayed, Gihan El Assal et al. · 2020 · Research Square
4. Evaluation of Remdesivir and Hydroxychloroquine on Viral Clearance in COVID-19 Patients: Results from the NOR-Solidarity Randomised Trial
   Andreas Barratt‐Due, Inge Christoffer Olsen, Katerina Nezvalova Henriksen et al. · 2021 · SSRN Electronic Journal
5. Preliminary clinical effect analysis of the treatment of novel coronavirus pneumonia by internal administration of traditional Chinese medicine plus fumigation and absorption combined with super dose of vitamin C in treating NOVID-19
   汪娅莉, 杨旭东, 刘永平 · 2020
6. Hydroxychloroquine Alone or in Combination with Cobicistat-Boosted Darunavir for Treatment of Mild COVID-19: A Cluster-Randomized Clinical Trial
   Oriol Mitjà, Marc Corbacho‐Monné, Camila González-Beiras et al. · 2020 · SSRN Electronic Journal
7. Efficacy and Safety of Sofosbuvir/Daclatasvir in the Treatment of COVID-19: A Randomized, Controlled Study
   Mostafa Yakoot, Basem E. Eysa, Essam Gouda et al. · 2020 · SSRN Electronic Journal
8. Treatment with an Anti-CK2 Synthetic Peptide Improves Clinical Response in Covid-19 Patients with Pneumonia. A Randomized and Controlled Clinical Trial
   Leticia Rosario Cruz, Idania Baladrón, Aliusha Rittoles et al. · 2020 · medRxiv
9. Evaluation of the Efficacy of Arbidol in Comparison with the Standard Treatment Regimen of Hospitalized Patients with Covid-19: A Randomized Clinical Trial
   Davood Yadegarinia, Shabnam Tehrani, Sara Abolghasemi · 2020 · Archives of Clinical Infectious Diseases
10. Galectin antagonist use in mild cases of SARS-CoV-2; pilot feasibility randomised, open label, controlled trial
    Alben Sigamani, Samarth Shetty, Madhavi · 2020 · medRxiv
11. Nitazoxanide In Vitro Efficacy Against SARS CoV-2 and In Vivo Superiority to Placebo to Treat Moderate COVID-19 – A Phase 2 Randomized Double-Blind Clinical Trial
    Vinicius Fontanesi Blum, Sérgio Cimerman, James Hunter et al. · 2021 · SSRN Electronic Journal
12. Patient-important outcomes reported in randomized controlled trials of pharmacologic treatments for COVID-19: a protocol of a META-epidemiological study
    Mario A. Jiménez-Mora, Andrea Ramírez Varela, Jose Francisco Meneses-Echavez, Julia Bidonde, Adriana Angarita Fonseca, Reed Alexander Cunningham Siemieniuk, Dena Zeraatkar, Jessica Julia Bartoszko, Romina Brignardello‐Petersen, Kimia Honarmand et al. · 2021 · Systematic Reviews
13. Recombinant Super-Compound Interferon (rSIFN-co) Versus Interferon Alfa in the Treatment of Moderate-to-Severe COVID-19: A Multicentre, Randomised, Phase 2 Trial
    Chuan Li, Nian Xiong, Zhihua Xu et al. · 2020 · SSRN Electronic Journal
14. Evaluation of the efficacy and safety of hydroxychloroquine in comparison with chloroquine in moderate and severe patients with COVID-19
    Qiuyu Li, Cheng Cui, Fei Xu et al. · 2021 · Science China Life Sciences
15. WITHDRAWN: Proxalutamide (GT0918) Reduces the Rate of Hospitalization and Death in COVID-19 Male Patients: A Randomized Double-Blinded Placebo-Controlled Trial.
    Flavio Cadegiani, John M. McCoy, Carlos Gustavo Wambier · 2020 · Research Square
16. Role of doxycycline, oral steroids, and nasal steroid in treatment of anosmia due to COVID-19 with the new insights into the doxycycline activity.
    Parvez Husain, Shaheen Khalil Ahmed, Benazeer Husain · 2020 · Research Square
17. Itraconazole for COVID-19: Preclinical Studies and a Proof-of-Concept Pilot Clinical Study
    Laurens Liesenborghs, Isabel Spriet, Dirk Jochmans et al. · 2020 · SSRN Electronic Journal
18. Omega-3 polyunsaturated fatty acids supplementation improve clinical symptoms in patients with covid-19: A randomized clinical trial
    Mohsen Sedighiyan, Hamed Abdollahi, Elmira Karimi · 2021
19. Canakinumab to Reduce Deterioration of Cardiac and Respiratory Function in Sars-cov2 Associated Myocardial Injury With Heightened Inflammation (canakinumab in Covid-19 Cardiac Injury): Results From the Randomized Three C Study
    Paul C Cremer, Calvin Chen Sheng, Debasis H Sahoo et al. · 2020 · Circulation
20. Clinical Efficacy of Diammonium Glycyrrhizinate in the Treatment of Common Type Patients with Novel Coronavirus Pneumonia
    Waiming, Zhou, Fu-ming · 2020 · 病毒学报
21. An Investigation Into the Beneficial Effects of High-Dose Interferon beta 1-a, Compared to Low-Dose Interferon Beta 1-a (the base therapeutic regimen) in moderate to severe COVID-19
    Ilad Alavi Darazam, Firouze Hatami, Mohammad Mahdi Rabiei et al. · 2021 · Research Square
22. Efficacy and Safety of Levamisole Treatment in Clinical Presentations of Patients With COVID-19: A Double-Blind, Randomized, Controlled Trial
    Amir Roostaei, Zohreh Akhoundi Meybodi, Seyed Rohollah Mosavinasab · 2021 · Research Square